Welcome 2025! I am very excited about our TTS-TID section and the opportunities we have in 2025. Our mission continues be to promote research and education in the prevention, diagnosis, clinical consequences, and management of infectious disease problems of the transplant recipient.

We had a very exciting and productive 2024 and I would like to thank the TTS-TID section Executive officers (Wanessa Clemente, Ban Hock Tan, Cameron Wolfe) and council members (Jonathon Hand, Maricar Malinis, Alessandra Mularoni, Maristela Pinheiro Freire, Stephanie Pouch, Marcelo Radisic, Matthew Roberts, Monica Slavin, Ines Ushiro-Lumb, Siriorn Watcharananan) and other volunteers who helped make 2024 a wonderful year for our section and its membership. A summary of our group and activities can be found at www.tts.org/tid. I have highlighted a few activities from 2024 and early 2025, below:

• Development of new Membership, Research and Communications sub-committees
• Continued collaboration with the Transplant Infectious Diseases Journal
• Meetings:
  • TID 2024, held as pre-meeting workshop at TTS, Istanbul 2024
• Webinars:
  • February 6, 2025 (Part of TTS Education Committee Webinar Series): Global Adventures after Pandemic: Ensuring Safe Travels for Transplant Patients
  • July 9, 2024 (Part of TTS Education Committee Webinar Series): CMV in Transplantation: Facing Challenges and Advances
• TID Clinicopathological Series:
  • October 10, 2024: Unraveling the Mystery: Abdominal Pain in a Solid Organ Transplant Recipient
  • July 5, 2024: Seizures and Lung Lesions in a Solid Organ Transplant Recipient
  • May 8, 2024: Hemorrhage Incognito: An Unusual Cause of Hemorrhage in a Kidney Transplant Recipient
  • April 3, 2024: Riders on the Storm
• Collaboration with ISHLT Infectious Disease Professional Community on Measles update in transplant patients
• Co-sponsored Symposium with the International Immunocompromised Host Society, April 2024
• Development of consensus guideline about standardized reporting of infection events in immunocompromised patients (Lancet Infect Dis. 2024).

We plan to continue our progress with a productive 2025, with additional webinars and Clinicopathological Series, co-sponsored by ESCMID Immunocompromised host sub-group. We also made an effort to increase research activities. Currently, several survey-based research projects are ongoing. We are currently seeking help from members to participate in committees or other projects that align with our mission. Please contact me if you have any interest or any questions.

Finally, we will be holding Council elections in the spring of 2025. As you can see, our TID council remains active and will continue to provide our members with a good experience. We hope you can contribute in the future. Please consider joining us on the council, by a self-nomination, or asking a colleague to nominate you. More details are forthcoming.

Sincerely,

John W. Baddley, MD, MSPH
President, TTS-TID Section Director, Transplant and Oncology Infectious Diseases
Johns Hopkins University School of Medicine